The effect of lidocaine injection in tender points of head in patients with chronic daily headaches

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200305046704N1

Enrollment

Registered

2020-03-11

Start date

2020-03-10

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic daily headache.

Interventions

Intervention group: headache patients with tenderness points.

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: chronic daily headache

Exclusion criteria

Exclusion criteria: Head injury history Head Surgery Brain tumors depression and anxiety

Design outcomes

Primary

Measure	Time frame
Average daily headache severity. Timepoint: One week, one month, two months and three months after injection. Method of measurement: HIT6 , VAS score.	—

Secondary

Measure	Time frame
The number of days a week a patient has a headache. Timepoint: One week, one month, two months and three months after injection. Method of measurement: Headache Impact Test Questionnaire(HIT6).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDavood Kashipazha

Ahvaz University of Medical Sciences

dakashi47@gmail.com+98 61 3374 3012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026